NRx Pharmaceuticals, Inc. Stock News

The company announced progress on two fronts for its experimental COVID-19 drug Zyesami.

RADNOR, Pa., Sept. 29, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (NASDAQ: NRXP), a clinical stage, biopharmaceutical company today provided a safety update on ZYESAMI™ (aviptadil) which is bein

NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced top-line data demonstrating improved outcomes at one year in highly comorbid patients with COVID-19 treated with Zyesami. Between June and Septe

RADNOR, Pa., Sept. 27, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), a clinical stage, biopharmaceutical company, today announced top line data demonstrating improved outcomes at one year

IQVIA (IQV) and NRx are set to work closely to support activities essential for emergency use authorization of ZYESAMI.

Iqvia Holdings Inc (NYSE: IQV) has collaborated with NRx Pharmaceuticals Inc (NASDAQ: NRXP) to provide pharmacovigilance services and medical information in preparation for potential regulatory a

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry,

RADNOR, Pa., Sept. 8, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) today announced that NRx's management team will present and host one-on-one investor meetings at the upcoming H.C.

NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced an additional finding from its Phase 2b/3 trial investigating Zyesami (aviptadil) for critically ill COVID-19 patients with acute respiratory fa

RADNOR, Pa., Aug. 30, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced an additional finding in its phase 2b/3 clinical trial investigating ZYESAMI™ (aviptadil) for the treat

NRx Pharmaceuticals Inc (NASDAQ: NRXP) has signed an agreement with Cardinal Health Inc (NYSE: CAH) to provide third-party logistics and distribution of Zyesami upon the potential FDA Emergency Use Au

The stock price of NRx Pharmaceuticals (Nasdaq: NRXP) increased by over 16% during intraday trading. This is why it happened.

RADNOR, Pa., Aug. 26, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today it has signed an agreement with Cardinal Health to provide third party logistics and distribution of

RADNOR, Pa., Aug. 24, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), today announced that it has completed its previously announced private placement for the purchase of 2,727,273 shares of

Investors cheered reports in Israel that COVID-19 vaccine candidate BriLife appears to provide protection for at least six months after a second dose.